A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment in patients with locally advanced rectal cancer†

OBJECTIVE: To evaluate the activity and safety of adding oxaliplatin to a standard chemoradiotherapy schema, including 5-fluorouracil (5-FU)/folinic acid (FA), in locally-advanced rectal cancer (LARC). METHODS: Two cycles of oxaliplatin 130 mg/m(2) plus FA 20 mg/m(2) bolus for 5 days and 5-FU 350 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitapanarux, I, Chitapanarux, T, Tharavichitkul, E, Mayurasakorn, S, Siriwittayakorn, P, Yamada, S, Lorvidhaya, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265185/
https://www.ncbi.nlm.nih.gov/pubmed/22279502
http://dx.doi.org/10.2349/biij.7.4.e25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265185/
https://www.ncbi.nlm.nih.gov/pubmed/22279502
http://dx.doi.org/10.2349/biij.7.4.e25

Ejemplares similares